The pandemic influenza vaccine challenge

Vaccine

Volumn 26, Issue SUPPL. 4, 2008, Pages

  Kieny, Marie Paule ^a   Fukuda, Keiji ^a  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS HEMAGGLUTININ;

EDITORIAL; EPIDEMIC; HUMAN; IMMUNOGENICITY; INFLUENZA; INFLUENZA VACCINATION; INFLUENZA VIRUS A H5N1; NONHUMAN; PANDEMIC; PRIORITY JOURNAL; VACCINE PRODUCTION; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS STRAIN; VIRUS TRANSMISSION;

DISEASE OUTBREAKS; HUMANS; INFLUENZA VACCINES; INFLUENZA, HUMAN;

EID: 51649101079     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2008.07.046     Document Type: Editorial

References (9)

1. Blumenfeld H., Kilbourne E., Louria D., and Rogers D. Studies on influenza in the Pandemic of 1957-1958. An epidemiologic, clinical and serologic investigation of an intrahospital epidemic, with a note on vaccination efficacy. J Clin Invest 38 1 Part 2 (1959) 199-212
2. Mogabgab W., and Leiderman E. Immunogenicity of 1967 polyvalent and 1968 Hong Kong influenza vaccines. JAMA 211 10 (1970) 1672-1676
3. Ferguson N.M., Cummings D.A., Fraser C., Cajka J.C., Cooley P.C., and Burke D.S. Strategies for mitigating an influenza pandemic. Nature 442 7101 (2006) 448-452
4. Francis T.J. The development of the 1943 vaccination study of the Commission on Influenza. Am J Hyg 42 (1945) 1-11
5. Harper S.A., Fukuda K., Cox N.J., and Bridges C.B. Advisory Committee on Immunization Practices. Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 52 RR-13 (2003) 1-8
6. Alexandrova G.I., Budilovsky G.N., Koval T.A., Polezhaev F.I., Garmashova L.M., Ghendon Y.Z., et al. Study of live recombinant cold-adapted influenza bivalent vaccine of type A for use in children: an epidemiological control trial. Vaccine 4 (1986) 114-118
7. Stephenson I., Gust I., Pervikov Y., and Kieny M.P. Development of vaccines against influenza H5. Lancet Infect Dis 6 8 (2006) 458-460
8. Hampson A.W., Osterhaus A.D., Pervikov Y., and Kieny M.P. Report of the second meeting on the development of influenza vaccines that induce broad-spectrum and long-lasting immune responses, World Health Organization, Geneva, Switzerland, 6-7 December 2005. Vaccine 24 23 (2006) 4897-4900
9. Kieny M.P., Costa A., Hombach J., Carrasco P., Pervikov Y., Salisbury D., et al. A global pandemic influenza vaccine action plan. Vaccine 24 40-41 (2006) 6367-6370